Spirometra erinaceieuropaei
Spirometra erinaceieuropaei is a species of tapeworm that is known to infect both animals and humans. This tapeworm is a member of the family Diphyllobothriidae and is the causative agent of a disease known as sparganosis.
Life Cycle[edit]
The life cycle of Spirometra erinaceieuropaei involves several hosts. The primary hosts are typically carnivores such as dogs or cats, while the intermediate hosts can be a variety of animals including frogs, snakes, and rodents. Humans can become infected by consuming undercooked meat from an infected intermediate host, or by drinking water contaminated with the parasite's eggs.
Symptoms and Diagnosis[edit]
In humans, infection with Spirometra erinaceieuropaei can lead to a variety of symptoms, including abdominal pain, nausea, and diarrhea. In some cases, the parasite can migrate to other parts of the body, leading to more serious complications such as seizures or neurological damage.
Diagnosis of Spirometra erinaceieuropaei infection is typically made through the identification of the parasite's eggs in a stool sample. However, this can be challenging as the eggs are often passed intermittently and may not be present in every sample.
Treatment and Prevention[edit]
Treatment for Spirometra erinaceieuropaei infection typically involves the use of antiparasitic medications. In some cases, surgical removal of the parasite may be necessary.
Prevention of Spirometra erinaceieuropaei infection involves avoiding consumption of undercooked meat from potential intermediate hosts, and ensuring that drinking water is free from contamination.
See Also[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
Medical weight loss NYC | Affordable GLP-1 injections NYC | Budget GLP-1 weight loss shots Philadelphia | New Jersey medical weight loss | NYC medical weight loss | Philadelphia medical weight loss | Sleep clinic NYC | W8MD's Philadelphia GLP-1 doctor | Weight loss prescriptions NYC
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
